A recent work characterized the behavior of immune cells during vitiligo onset in melanoma patients and revealed an association between a blood reduction in CD8-mucosal associated invariant T, T helper (Th) 17, natural killer (NK), CD56 bright, and T regulatory (T-reg) cells and vitiligo onset. This evidence concerns the gene NCAM1 and melanoma.